MacroGenics
MGNX
#8794
Rank
S$0.30 B
Marketcap
S$4.79
Share price
5.35%
Change (1 day)
118.55%
Change (1 year)

MacroGenics (MGNX) - Total assets

Total assets on the balance sheet as of June 2026 : S$0.44 Billion

According to MacroGenics's latest financial reports the company's total assets are S$0.44 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

MacroGenics - Total assets on balance sheet (from 2012 to 2026)

Total assets by year

Year Total assets Change
2025-12-31S$0.32 B-7.28%
2024-12-31S$0.35 B-9.76%
2023-12-31S$0.39 B4.82%
2022-12-31S$0.37 B-17.04%
2021-12-31S$0.45 B-9.55%
2020-12-31S$0.50 B18.93%
2019-12-31S$0.42 B-7.15%
2018-12-31S$0.45 B-9.26%
2017-12-31S$0.50 B11.01%
2016-12-31S$0.45 B-11.36%
2015-12-31S$0.50 B121.18%
2014-12-31S$0.22 B44.18%
2013-12-31S$0.15 B142.46%
2012-12-31S$65.72 M-19.03%
2011-12-31S$81.17 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
S$257.52 B 58,129.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$182.17 B 41,092.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$122.45 B 27,588.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$63.20 B 14,190.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$166.19 B 37,479.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$112.20 B 25,271.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S$0.92 B 109.88%๐Ÿ‡บ๐Ÿ‡ธ USA